chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Chills, Choking, Cough
Clinical narrative: severe pain emanating from injection site; traveled upward over shoulder; continued up right side of neck; heavy right earache; sore throat; headache forehead and across top of my head; dry heaves; feverish/chills/shivering; feverish/chills/shivering; words mixed up; Felt pain in center chest; congestion across bronchial area and developed upper respiratory congestion temporarily; congestion across bronchial area and developed upper respiratory congestion temporarily; fatigued; had severe coughing spell which included choking and further nausea; had severe coughing spell which included choking and further nausea; severe nausea; Ripple effect across bridge of nose; strong metallic odor and taste within mouth; moving from back of throat and nostrils; it is both painful and difficult to raise my right arm very high; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EN6060, first dose) solution for injection intramuscular in the right arm on 09Mar2021 at 16:00 (at the age of 77-years-old) at single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: yes. Concomitant medication included vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 09Mar2021 16:15, the patient had severe coughing spell which included choking and further nausea, ripple effect across bridge of nose, strong metallic odor and taste within mouth moving from back of throat and nostrils, it is both painful and difficult to raise my right arm very high. On 10Mar2021, the patient experienced dry heaves, feverish/chills/shivering, words mixed up, felt pain in center chest, congestion across bronchial area and developed upper respiratory congestion temporarily, fatigued. On 10Mar2021 03:00 the patient had severe pain emanating from injection site traveled upward over shoulder continued up right side of neck heavy right earache, sore throat, headache forehead and across top of my head. Unspecified treatment was provided for the events. The outcome of the events choking, coughing, nausea, ripple effect across bridge of nose, strong metallic odor and taste and smell, severe pain emanating from injection site upward over shoulder continued up right side of neck heavy right earache, sore throat, headache, dry heaves, feverish, chills/shivering, words mixed up, Felt pain in center chest, painful and difficult to raise my right arm very high, fatigued was not recovered. The outcome of the event congestion across bronchial area and developed upper respiratory congestion temporarily was recovering. Since the vaccination, the patient has not been tested for COVID-19.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Ear pain, Fatigue, Headache, Lower respiratory tract congestion
Clinical narrative: severe pain emanating from injection site; traveled upward over shoulder; continued up right side of neck; heavy right earache; sore throat; headache forehead and across top of my head; dry heaves; feverish/chills/shivering; feverish/chills/shivering; words mixed up; Felt pain in center chest; congestion across bronchial area and developed upper respiratory congestion temporarily; congestion across bronchial area and developed upper respiratory congestion temporarily; fatigued; had severe coughing spell which included choking and further nausea; had severe coughing spell which included choking and further nausea; severe nausea; Ripple effect across bridge of nose; strong metallic odor and taste within mouth; moving from back of throat and nostrils; it is both painful and difficult to raise my right arm very high; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EN6060, first dose) solution for injection intramuscular in the right arm on 09Mar2021 at 16:00 (at the age of 77-years-old) at single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: yes. Concomitant medication included vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 09Mar2021 16:15, the patient had severe coughing spell which included choking and further nausea, ripple effect across bridge of nose, strong metallic odor and taste within mouth moving from back of throat and nostrils, it is both painful and difficult to raise my right arm very high. On 10Mar2021, the patient experienced dry heaves, feverish/chills/shivering, words mixed up, felt pain in center chest, congestion across bronchial area and developed upper respiratory congestion temporarily, fatigued. On 10Mar2021 03:00 the patient had severe pain emanating from injection site traveled upward over shoulder continued up right side of neck heavy right earache, sore throat, headache forehead and across top of my head. Unspecified treatment was provided for the events. The outcome of the events choking, coughing, nausea, ripple effect across bridge of nose, strong metallic odor and taste and smell, severe pain emanating from injection site upward over shoulder continued up right side of neck heavy right earache, sore throat, headache, dry heaves, feverish, chills/shivering, words mixed up, Felt pain in center chest, painful and difficult to raise my right arm very high, fatigued was not recovered. The outcome of the event congestion across bronchial area and developed upper respiratory congestion temporarily was recovering. Since the vaccination, the patient has not been tested for COVID-19.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Oropharyngeal pain, Pain in extremity, Parosmia
Clinical narrative: severe pain emanating from injection site; traveled upward over shoulder; continued up right side of neck; heavy right earache; sore throat; headache forehead and across top of my head; dry heaves; feverish/chills/shivering; feverish/chills/shivering; words mixed up; Felt pain in center chest; congestion across bronchial area and developed upper respiratory congestion temporarily; congestion across bronchial area and developed upper respiratory congestion temporarily; fatigued; had severe coughing spell which included choking and further nausea; had severe coughing spell which included choking and further nausea; severe nausea; Ripple effect across bridge of nose; strong metallic odor and taste within mouth; moving from back of throat and nostrils; it is both painful and difficult to raise my right arm very high; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EN6060, first dose) solution for injection intramuscular in the right arm on 09Mar2021 at 16:00 (at the age of 77-years-old) at single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: yes. Concomitant medication included vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 09Mar2021 16:15, the patient had severe coughing spell which included choking and further nausea, ripple effect across bridge of nose, strong metallic odor and taste within mouth moving from back of throat and nostrils, it is both painful and difficult to raise my right arm very high. On 10Mar2021, the patient experienced dry heaves, feverish/chills/shivering, words mixed up, felt pain in center chest, congestion across bronchial area and developed upper respiratory congestion temporarily, fatigued. On 10Mar2021 03:00 the patient had severe pain emanating from injection site traveled upward over shoulder continued up right side of neck heavy right earache, sore throat, headache forehead and across top of my head. Unspecified treatment was provided for the events. The outcome of the events choking, coughing, nausea, ripple effect across bridge of nose, strong metallic odor and taste and smell, severe pain emanating from injection site upward over shoulder continued up right side of neck heavy right earache, sore throat, headache, dry heaves, feverish, chills/shivering, words mixed up, Felt pain in center chest, painful and difficult to raise my right arm very high, fatigued was not recovered. The outcome of the event congestion across bronchial area and developed upper respiratory congestion temporarily was recovering. Since the vaccination, the patient has not been tested for COVID-19.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Retching, Sensory disturbance, Speech disorder, Upper respiratory tract congestion
Clinical narrative: severe pain emanating from injection site; traveled upward over shoulder; continued up right side of neck; heavy right earache; sore throat; headache forehead and across top of my head; dry heaves; feverish/chills/shivering; feverish/chills/shivering; words mixed up; Felt pain in center chest; congestion across bronchial area and developed upper respiratory congestion temporarily; congestion across bronchial area and developed upper respiratory congestion temporarily; fatigued; had severe coughing spell which included choking and further nausea; had severe coughing spell which included choking and further nausea; severe nausea; Ripple effect across bridge of nose; strong metallic odor and taste within mouth; moving from back of throat and nostrils; it is both painful and difficult to raise my right arm very high; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EN6060, first dose) solution for injection intramuscular in the right arm on 09Mar2021 at 16:00 (at the age of 77-years-old) at single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: yes. Concomitant medication included vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 09Mar2021 16:15, the patient had severe coughing spell which included choking and further nausea, ripple effect across bridge of nose, strong metallic odor and taste within mouth moving from back of throat and nostrils, it is both painful and difficult to raise my right arm very high. On 10Mar2021, the patient experienced dry heaves, feverish/chills/shivering, words mixed up, felt pain in center chest, congestion across bronchial area and developed upper respiratory congestion temporarily, fatigued. On 10Mar2021 03:00 the patient had severe pain emanating from injection site traveled upward over shoulder continued up right side of neck heavy right earache, sore throat, headache forehead and across top of my head. Unspecified treatment was provided for the events. The outcome of the events choking, coughing, nausea, ripple effect across bridge of nose, strong metallic odor and taste and smell, severe pain emanating from injection site upward over shoulder continued up right side of neck heavy right earache, sore throat, headache, dry heaves, feverish, chills/shivering, words mixed up, Felt pain in center chest, painful and difficult to raise my right arm very high, fatigued was not recovered. The outcome of the event congestion across bronchial area and developed upper respiratory congestion temporarily was recovering. Since the vaccination, the patient has not been tested for COVID-19.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: severe pain emanating from injection site; traveled upward over shoulder; continued up right side of neck; heavy right earache; sore throat; headache forehead and across top of my head; dry heaves; feverish/chills/shivering; feverish/chills/shivering; words mixed up; Felt pain in center chest; congestion across bronchial area and developed upper respiratory congestion temporarily; congestion across bronchial area and developed upper respiratory congestion temporarily; fatigued; had severe coughing spell which included choking and further nausea; had severe coughing spell which included choking and further nausea; severe nausea; Ripple effect across bridge of nose; strong metallic odor and taste within mouth; moving from back of throat and nostrils; it is both painful and difficult to raise my right arm very high; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EN6060, first dose) solution for injection intramuscular in the right arm on 09Mar2021 at 16:00 (at the age of 77-years-old) at single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: yes. Concomitant medication included vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 09Mar2021 16:15, the patient had severe coughing spell which included choking and further nausea, ripple effect across bridge of nose, strong metallic odor and taste within mouth moving from back of throat and nostrils, it is both painful and difficult to raise my right arm very high. On 10Mar2021, the patient experienced dry heaves, feverish/chills/shivering, words mixed up, felt pain in center chest, congestion across bronchial area and developed upper respiratory congestion temporarily, fatigued. On 10Mar2021 03:00 the patient had severe pain emanating from injection site traveled upward over shoulder continued up right side of neck heavy right earache, sore throat, headache forehead and across top of my head. Unspecified treatment was provided for the events. The outcome of the events choking, coughing, nausea, ripple effect across bridge of nose, strong metallic odor and taste and smell, severe pain emanating from injection site upward over shoulder continued up right side of neck heavy right earache, sore throat, headache, dry heaves, feverish, chills/shivering, words mixed up, Felt pain in center chest, painful and difficult to raise my right arm very high, fatigued was not recovered. The outcome of the event congestion across bronchial area and developed upper respiratory congestion temporarily was recovering. Since the vaccination, the patient has not been tested for COVID-19.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Pneumonitis, SARS-CoV-2 test, Vaccination failure
Clinical narrative: tested positive to covid.; tested positive to covid.; lot of inflammation in his lungs; This is a spontaneous report from contactable consumer. This consumer reported similar events for 2 patients. This report is the first of 2 patients. A 21-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) in Feb2021 at single dose for COVID-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient was at a gathering where 9 out of 10 people (himself included) tested positive to covid. The patient experienced 102 fever, trouble breathing which required treatment by nebulizer, lot of inflammation in his lungs. The patient experienced a similar reaction 3 days after the 2nd dose of the vaccine in Feb2021 however he had tested negative in Feb2021, but at the time of report, 3 weeks after the second dose, the patient was positive (Mar2021). The patient had a positive Covid-19 test one day after first vaccine dose administration. The patient resulted negative to Covid-19 test in Feb2021 (3 days after the 2nd dose) and three weeks after receiving second dose of suspect vaccine the patient resulted positive to Covid-19 test in Mar2021. The outcome of the events was unknow. Information on the Lot/Batch number has been requested.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Dyspnoea, Paraesthesia, Syncope
Clinical narrative: Collapsed; difficulty breathing; weakness; Pain in chest; tingling all over body.; This is a spontaneous report from a contactable consumer (parent).  A 28-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 10Mar2021 at 12:15 (Lot Number: EN6206) (at the age of 28-year-old) as single dose for COVID-19 immunisation.  Medical history included bipolar from an unknown date and unknown if ongoing. Concomitant medications included lamotrigine (LAMICTAL); amphetamine aspartate/ amphetamine sulfate/dexamphetamine saccharate/dexamphetamine sulfate (ADDERALL) and alprazolam (XANAX); all taken for an unspecified indication, start and stop date were not reported. On 10Mar2021 at 12:15, the patient collapsed and experienced difficulty breathing, weakness, pain in chest and tingling all over body. The events resulted in physician office visit. No therapeutic measures were taken as a result of the events.  The patient outcome of the events was not recovered.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Vitamin D, Vitamin D deficiency
Clinical narrative: Diagnosed with Vitamin D deficiency and Stage 4 Chronic Kidney Disease two days ago; Diagnosed with Vitamin D deficiency and Stage 4 Chronic Kidney Disease two days ago; This is a spontaneous report from a contactable consumer (wife). A 57-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number was not reported) via an unspecified route of administration, at the age of 57-year-old, on an unspecified date as single dose for covid-19 immunisation.  The patient medical history was not reported. There were no concomitant medications.  The patient was diagnosed with vitamin d deficiency and stage 4 chronic kidney disease on 08Mar2021 with outcome of unknown.    Information on the lot/ batch number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness
Clinical narrative: Within minutes I became very dizzy and could not move my head or my eyes without feeling like I would faint or fall over.; blood pressure was checked and found to be 155/110; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at the age of 25-year-old, via an unspecified route of administration, administered in left arm on 09Mar2021 15:45 (Lot Number: EN6206) as single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS), atrial septal defect, obsessive-compulsive disorder (OCD), depression, post-traumatic stress disorder (PTSD), and was normally hypotensive with an average of about 100/50. The patient has no known allergies. No COVID prior vaccination and no COVID test post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included fluvoxamine (FLUVOXAMIN), valaciclovir (VALACYCLOVIR), and hydroxyzine; all taken for an unspecified indication, start and stop date were not reported. On 09Mar2021 15:45 (also reported as within minutes), the patient became very dizzy and could not move her head or eyes without feeling like she would faint or fall over. Her blood pressure was checked and found to be 155/110, and she was normally hypotensive with an average of about 100/50. Her blood pressure dropped, and the dizziness went away within 1-2 hours. The patient received EMT treatment/monitoring for the events. The patient recovered from the events on an unspecified date.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine can not be excluded for the reported events of dizzy and blood pressure increased due to temporal relationship.  Case will be re-assessed upon the additional information provided. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Dementia, Diverticulitis, Dizziness, Gastrooesophageal reflux disease
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hiccups, Illness, Insomnia, Nausea, Pancreatitis
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vomiting, Weight, Weight decreased
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Confusional state, Diarrhoea, Diet refusal
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diverticulitis, Dizziness, Dysuria, Enuresis, Gait disturbance
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Gastrooesophageal reflux disease, Hiccups, Hypoaesthesia, Insomnia, Malaise
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Memory impairment, Nausea, Neuropsychiatric symptoms, Pancreatitis, Peripheral swelling
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral vascular disorder, Sensory disturbance, Urinary tract obstruction, Urine flow decreased, Vomiting
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Weight decreased
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201; Expiration date: 30Jun2021) on 27Feb2021 (14:27) as a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included broken right shoulder; dizziness (not ongoing); and "sugar diabetes". There were no concomitant medications. The patient previously took meclizine HCl for dizziness, and was not working; paracetamol (TYLENOL), and reported he would be feeling good, and then his symptoms would hit him again; and the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9581; Expiration date: 31May2021) on 06Feb2021 for COVID-19 immunization. On an unspecified date in 2021, the patient was "feeling dementia"; had diverticulitis; pancreatitis; could not stop hiccupping; and had gastroesophageal reflux disease (GERD). On 09Mar2021, the patient had nausea; stomach was upset; had vomited in quantities (described as "had filled up two containers of trash"); was sick as a dog as/sick all day; did not sleep at night; and had lost weight (lost 30 lbs.). On 10Mar2021, the patient had dizziness. The patient clarified that the dizziness reported was a different dizziness from what he had before. The patient had taken meclizine as treatment for dizziness; and paracetamol (TYLENOL) as treatment for the upset stomach and nausea. The outcome of the events was unknown for 'feeling dementia', 'diverticulitis', 'pancreatitis', 'could not stop hiccupping', 'gastroesophageal reflux disease (GERD)' and 'did not sleep at night'; was recovering for 'nausea', 'dizziness', 'vomited in quantities' and 'sick as a dog/sick all day'; and was not recovered for 'stomach was upset' and 'lost weight'.
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Body temperature, Chills, Electrocardiogram, Headache
Clinical narrative: chills; headache; nausea; muscle aches; mild temp; Atrial fib for 1 hour; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), intramuscular, administered in arm left on 18Jan2021 12:00 as a single dose for covid-19 immunisation. Medical history included bone disorder, plague prevention, cardiac disorder, sleep disorder, pancreatic disorder from an unknown date to 2015 which was stable, supraventricular tachycardia, and osteoporosis. Concomitant medications included ergocalciferol (VIT D) taken for bone disorder from an unspecified start date and ongoing; calcium (CALCIUM) taken for bone disorder from an unspecified start date and ongoing; rosuvastatin calcium (CRESTOR OD) taken for plague from an unspecified start date and ongoing; metoprolol succinate taken for cardiac disorder from Oct2019 and ongoing; zolpidem taken for sleep aid when needed from an unspecified start date and ongoing. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH 9899) on 29Dec2020 05:15 PM (at the age of 71-years-old), intramuscular on the left arm for Covid-19 immunization. On 20Jan2021, the patient experienced chills, headache, nausea, muscle aches, and mild temp. On an unspecified date in 2021, it was reported that the patient had Atrial fib for 1 hour as recorded on apple watch at 01:00 am and required visit to Physician Office. Treatment was Eliquis  5 mg twice a day. The patient underwent lab tests and procedures which included body electrocardiogram: 1 hour of Afib continuously beginning 01:05-02:10 AM on 02Jan2021. Comments: ECG in office at 09:00 or holder Zis: No continues AF but at her shot run of irritability. The outcome of the event Atrial fibrillation was unknown while recovered on 20Jan2021 for the rest of the events.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: chills; headache; nausea; muscle aches; mild temp; Atrial fib for 1 hour; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), intramuscular, administered in arm left on 18Jan2021 12:00 as a single dose for covid-19 immunisation. Medical history included bone disorder, plague prevention, cardiac disorder, sleep disorder, pancreatic disorder from an unknown date to 2015 which was stable, supraventricular tachycardia, and osteoporosis. Concomitant medications included ergocalciferol (VIT D) taken for bone disorder from an unspecified start date and ongoing; calcium (CALCIUM) taken for bone disorder from an unspecified start date and ongoing; rosuvastatin calcium (CRESTOR OD) taken for plague from an unspecified start date and ongoing; metoprolol succinate taken for cardiac disorder from Oct2019 and ongoing; zolpidem taken for sleep aid when needed from an unspecified start date and ongoing. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH 9899) on 29Dec2020 05:15 PM (at the age of 71-years-old), intramuscular on the left arm for Covid-19 immunization. On 20Jan2021, the patient experienced chills, headache, nausea, muscle aches, and mild temp. On an unspecified date in 2021, it was reported that the patient had Atrial fib for 1 hour as recorded on apple watch at 01:00 am and required visit to Physician Office. Treatment was Eliquis  5 mg twice a day. The patient underwent lab tests and procedures which included body electrocardiogram: 1 hour of Afib continuously beginning 01:05-02:10 AM on 02Jan2021. Comments: ECG in office at 09:00 or holder Zis: No continues AF but at her shot run of irritability. The outcome of the event Atrial fibrillation was unknown while recovered on 20Jan2021 for the rest of the events.   Information on the lot/batch number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Confusional state, Dizziness, Headache, Magnetic resonance imaging
Clinical narrative: Dizziness; Muscle weakness in arms and legs; speech difficulty; headache; mental fog and confusion; mental fog and confusion; This is a spontaneous report from a non-contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in the left arm on 26Feb2021 17:00 as a single dose for COVID-19 immunisation. Medical history included COVID from an unknown date prior vaccination. The patient had no known allergies. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks. The patient experienced dizziness muscle weakness in arms and legs, speech difficulty, headache, mental fog and confusion on 01Mar2021 09:45AM. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and hospitalization for four (4) days. Treatment included, MRI, CT scan, and "migraine cocktail" on unspecified date. Outcome of the events was not recovered. The patient had a nasal swab Covid test post vaccination on 01Mar2021 with Negative result.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Mental impairment, Muscular weakness, SARS-CoV-2 test, Speech disorder
Clinical narrative: Dizziness; Muscle weakness in arms and legs; speech difficulty; headache; mental fog and confusion; mental fog and confusion; This is a spontaneous report from a non-contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in the left arm on 26Feb2021 17:00 as a single dose for COVID-19 immunisation. Medical history included COVID from an unknown date prior vaccination. The patient had no known allergies. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks. The patient experienced dizziness muscle weakness in arms and legs, speech difficulty, headache, mental fog and confusion on 01Mar2021 09:45AM. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and hospitalization for four (4) days. Treatment included, MRI, CT scan, and "migraine cocktail" on unspecified date. Outcome of the events was not recovered. The patient had a nasal swab Covid test post vaccination on 01Mar2021 with Negative result.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness
Clinical narrative: Started losing her hearing; She could not hear at all; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 01Mar2021 (Monday) (Lot number: EN6198, reporter was not sure) (at the age of 74-year-old) as single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient started losing her hearing on 02Mar2021 (Tuesday), she could not hear at all on 07Mar2021 (Sunday). Therapeutic measures were taken as a result of the events and included a specialist visit, she was prescribed some steroids as treatment. The patient outcome of the events was unknown.    Information on the lot/batch number has been requested.